Benefits
Oxidative stress markers during an alcohol challenge
In a placebo-controlled crossover of 16 men who drank alcohol at 1 g/kg body weight, one 250 mg capsule of clove bud polyphenol extract lowered markers of oxidative stress and lipid peroxidation and raised glutathione and superoxide dismutase compared with placebo. The study was small, run by the extract maker, and measured blood markers over 12 hours.
C-reactive protein and IL-6 after drinking
In the same 16-man crossover, C-reactive protein and IL-6, two blood markers of inflammation, were lower after the clove bud extract than after placebo, and the hangover severity score was 55% lower. These are short-term markers from one maker-run study; they do not show protection of the liver or make heavy drinking safer.
Blood sugar and lipid markers compared with synthetic glutathione
In 70 adults with metabolic syndrome, 84 days of a clove bud extract (250 mg/day) improved fasting and post-meal glucose, HbA1c, insulin and blood lipids, while synthetic glutathione showed no significant effect on glucose or lipids. There was no placebo arm, and the extract maker co-authored the study.
Post-meal blood sugar in healthy volunteers
In 13 young adults taking 250 mg of a clove bud extract after lunch for 30 days, 2-hour post-meal glucose fell about 13 to 17 mg/dL from baseline. The study had no control group or blinding and was funded by the maker. A review of spices for blood sugar in type 2 diabetes found too few clove studies to analyze.
Antioxidant enzymes over 30 days
Healthy office workers who took 250 mg a day of a de-flavored clove bud extract for 30 days, in capsules or foods, showed higher catalase, superoxide dismutase, glutathione peroxidase and glutathione and lower lipid peroxidation. No control group is described, and the extract maker ran the study.
Fat storage and blood sugar in lab and animal studies
In mice on a high-fat diet, 0.5% clove bud extract for 9 weeks lowered weight gain, body fat, blood lipids, glucose and insulin. In diabetic mice, a clove extract with most of its eugenol removed lowered blood glucose and HbA1c. These are animal and cell findings that have not been confirmed in people.
Mechanism of action
Polyphenols and eugenol act differently
Clove bud contains two distinct groups of compounds. In lab tests, the clove compound eugeniin blocked glycogen phosphorylase, an enzyme that releases stored glucose from the liver, and cut glucose output from liver cells, while eugenol had no effect. The supplement extracts studied in people are standardized for polyphenols, not eugenol.
Fat-building genes in animal tissue
In mice on a high-fat diet, clove bud extract reduced liver and fat-tissue levels of proteins that drive fat formation, including SREBP-1, fatty acid synthase, CD36 and PPAR-gamma, and blocked fat-cell formation in a cell line. These are animal and cell findings.
Eugenol and acetyl eugenol slow platelet clumping in the lab
In human platelets in the test tube, eugenol and acetyl eugenol from clove oil inhibited aggregation triggered by arachidonate, adrenaline and collagen, partly by lowering thromboxane formation. No study has measured this effect in people taking clove supplements, but it is the basis for bleeding cautions.
Clinical trials
Randomized, double-blind, placebo-controlled crossover; one 250 mg capsule of a clove bud polyphenol extract (Clovinol) or placebo with alcohol at 1 g/kg body weight, reversed after a 2-week washout; blood sampled over 12 hours. Four of the five authors are from the extract maker (Akay). (Mammen et al. 2018, J Med Food)
16 male social drinkers.
Compared with placebo, blood acetaldehyde cleared faster, markers of oxidative stress, lipid peroxidation, C-reactive protein and IL-6 were lower, glutathione and superoxide dismutase were higher, and the hangover severity score was 55% lower. A small maker-run study of blood markers over one drinking session; it does not show liver protection or make drinking safer.
Randomized, double-blind, active-controlled trial of a clove bud polyphenol extract (Clovinol) versus synthetic glutathione, each 250 mg/day for 84 days, with no placebo arm. Outcomes included plasma glutathione, Nrf2 and antioxidant enzymes, glucose and lipid markers, and inflammatory markers; the abstract reports higher plasma glutathione, Nrf2, antioxidant enzymes and GSH/GSSG ratio and lower IL-1beta, TNF-alpha and neutrophil/lymphocyte ratio with the clove extract. Not PubMed-indexed; read from its published abstract only. Two authors from the extract maker. (Thomas et al. 2022, J Funct Foods)
70 adults with metabolic syndrome.
The abstract reports that the clove extract arm improved fasting and post-meal glucose, HbA1c, HOMA-IR, insulin and blood lipids, while the comparator showed no significant effect on glucose or lipids. Between-arm statistics were not available to us. With no placebo arm, the trial cannot show how much of the change beats no treatment. No significant side effects or blood-test changes were reported.
Open-label, unblinded pilot with no control group; 250 mg of a water-soluble clove bud polyphenol extract after lunch daily for 30 days, glucose measured by glucometer before and 2 hours after lunch. Funded by the extract maker (Akay). (Mohan et al. 2019, BMC Complement Altern Med)
13 adults aged 25 to 35 (10 men, 3 women): 7 with pre-meal glucose up to 100 mg/dL and 6 with 101 to 125 mg/dL.
Post-meal glucose fell from baseline by about 13 mg/dL and 17 mg/dL in the two groups by day 12 and stayed lower through day 30. Pre-meal glucose fell only in the higher-glucose group (about 13 mg/dL at days 24 and 30). Without a comparison group, changes in diet or routine cannot be ruled out.
Product development paper with a 30-day intake study of a clove bud polyphenol extract (Clovinol) at 250 mg a day in capsules or added to foods and drinks; the abstract describes no placebo or control group. Outcomes were blood antioxidant enzymes (catalase, superoxide dismutase, glutathione peroxidase), glutathione and lipid peroxidation. Authors from the extract maker. (Johannah et al. 2015, Food Funct)
Healthy adult office workers; number not given in the abstract.
Average levels of the first four markers rose about 33%, 66%, 56% and 167%, and the membrane damage marker fell about 81%, measured before and after intake with no comparison group. These are blood markers, not health outcomes.
Acute (5 g/kg) and 90-day (0.25, 0.5 and 1 g/kg a day) oral toxicity tests in Wistar rats plus Ames mutagenicity tests of a clove bud polyphenol extract (Clovinol); co-authored by the extract maker. (Vijayasteltar et al. 2016, Toxicol Rep)
Wistar rats and Salmonella typhimurium test strains; no people.
No toxicologically significant changes in behavior, weight, blood tests, urine or organ tissue versus untreated rats; the no-observed-adverse-effect level was 1000 mg/kg a day, the highest dose tested. No mutagenic activity was found. These results apply to this polyphenol extract, not to clove oil, which is mostly eugenol.